Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.

about

Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.

Item

http://www.wikidata.org/entity/Q49666677

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Temporal retinal thinning and ...... basement membrane nephropathy.

@en

Temporal retinal thinning and ...... basement membrane nephropathy.

@nl

type

Item

label

Temporal retinal thinning and ...... basement membrane nephropathy.

@en

Temporal retinal thinning and ...... basement membrane nephropathy.

@nl

prefLabel

Temporal retinal thinning and ...... basement membrane nephropathy.

@en

Temporal retinal thinning and ...... basement membrane nephropathy.

@nl

P1476

Temporal retinal thinning and ...... basement membrane nephropathy

@en

P2093

Deb Colville

http://www.w3.org/2001/XMLSchema#string

Francesco Ierino

http://www.w3.org/2001/XMLSchema#string

Judy Savige

http://www.w3.org/2001/XMLSchema#string

Yan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome

Ocular features in Alport syndrome: pathogenesis and clinical significance

Identification of mutations in the COL4A5 collagen gene in Alport syndrome

Thin basement membrane nephropathy

Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Retinal basement membrane abnormalities and the retinopathy of Alport syndrome

Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys

Temporal macular thinning associated with X-linked Alport syndrome.

Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum.

P304

208-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13816810.2017.1401088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

R C Symons

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29172845

http://www.w3.org/2001/XMLSchema#string